BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 23, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Ongoing coverage of the Ebola outbreak
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Maxygen and Cangene sign licensing agreement for MAXY-G34 in ARS
May 11, 2009
Oxygen Biotherapeutics files orphan drug application with FDA for Oxycyte
May 8, 2009
Amsterdam Molecular treats first patient in preregistration clinical trial of Glybera
May 8, 2009
FDA approves VeroScience's Cycloset for type 2 diabetes
May 7, 2009
FDA grants orphan drug designation to Hyperion's HPN-100 for urea cycle disorders
May 7, 2009
Novel PPAR agonists for the treatment of diabetes discovered by GlaxoSmithKline
May 7, 2009
ProStrakan files response to the FDA's action letter regarding the NDA for Fortigel
May 7, 2009
Merck Serono launches powder formulation of Glucophage in France and U.K.
May 7, 2009
Bayer's low-dose contraceptive patch begins phase III
May 6, 2009
Zoraxel improves erectile function in phase IIa study
May 6, 2009
Previous
1
2
…
773
774
775
776
777
778
779
780
781
…
1793
1794
Next
RSS